Mark Matson

Mark is a research professional with 25 years in drug development, sales leadership, licensing, and program management. Mark’s experience includes an extensive career at Pfizer in R&D, program leadership at the biotech MannKind Corporation, and stints in sales and sales leadership at IQVIA, Covance, and ICON. Mark joined Medidata through the acquisition of MC10 where he was the VP of Sales.  Having earned an honors degree in molecular and cellular from the University of Connecticut, an MBA from Rensselaer Polytechnic Institute, and multiple executive leadership certificates from the Harvard Business School, Mark has been involved in most aspects of drug development throughout his career and is a seasoned corporate leader.